Medical Boards Formed Workgroup for AI Regulation
The 22-member task force met in Washington to draft guidelines for AI tools performing unsupervised clinical functions.
Updated on Oct. 14, 2026 in Artificial Intelligence
Live Poll
Do you trust medical AI tools to perform clinical functions without direct physician supervision?
The Federation of State Medical Boards has convened a 22-member workgroup to develop regulatory guidelines for artificial intelligence in medicine. These efforts focus specifically on AI systems that execute clinical tasks with limited or no direct physician oversight.
Why it matters
The workgroup aims to establish a framework that will assist local medical boards in governing autonomous AI tools within clinical practice. These recommendations may eventually serve as the foundation for future state-level legislation.
The workgroup comprises 22 representatives from medical, hospital, and technology sectors, including the American Medical Association, American Hospital Association, Anthropic, and Elevance Health.
The players
Federation of State Medical Boards
An organization representing state medical regulatory agencies that oversee physician licensing and practice standards.
Anthropic
An artificial intelligence safety and research company known for developing large language models with a focus on constitutional AI.
American Medical Association
The largest association of physicians and medical students in the country, focused on setting health policy and practice standards.
American Hospital Association
A national organization representing hospitals and healthcare networks across the country.
Elevance Health
A major health insurance and services provider that manages large-scale health data and clinical systems.
The details
The group is developing guidelines through a series of closed-door meetings in Washington, D.C. The primary objective is to define the boundary for clinical AI tools that function without physician supervision. Once drafted, these recommendations will undergo a public feedback process before final adoption by state boards.
Timeline
The workgroup held its initial meetings in Washington, D.C. in early October 2026.
A draft of the proposed recommendations is expected to be released within weeks to months.
The Tech Race
This effort parallels federal initiatives to establish AI safety guardrails for critical infrastructure and professional sectors. It marks a shift from general national guidance toward the creation of enforceable state-level regulations for clinical software.
These guidelines will ultimately define the scope of autonomous AI tools accessible to clinicians in their daily workflows. The public will have an opportunity to provide input on the proposed regulations during a feedback period occurring before any state-level adoption.
The takeaway
The move signifies that the integration of AI into medicine is moving toward a formal period of state-level oversight. Readers should watch for the publication of the draft recommendations, which will contain the specific technical requirements for future clinical AI systems.
Further reading
Learn more about the latest developments in Artificial Intelligence as oversight bodies begin to codify regulatory frameworks for automated clinical tools.
Live Poll
Do you trust medical AI tools to perform clinical functions without direct physician supervision?
